icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
8 weeks sofosbuvir/velpatasvir in genotype 3 patients with significant fibrosis: Highly effective amongst an OST cohort
 
 
  Reported by Jules Levin
EASL April 13 Paris France
 
Alison Boyle1, F Marra1, E Peters1 , M Heydtmann2 , H Cairns1, S Datta3 , ST Barclay4 1Gartnavel General Hospital, Glasgow, Scotland, 2Royal Alexandra Hospital, Paisley, Scotland, 3Queen Elizabeth University Hospital, Glasgow, Scotland, 4Glasgow Royal Infirmary, Glasgow, Scotland

0413181

0413182

0413183

0413184

0413185

0413186

0413187

0413188